Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 09:54 am Purchase |
2022-12-31 | 13G | Fate Therapeutics, Inc. FATE |
STATE STREET CORP STT |
5,935,459 6.110% |
5,935,459 (New Position) |
Filing History |
| 2023-01-06 12:23 pm Purchase |
2022-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
9,725,895 10.000% |
2,665,343 (+37.75%) |
Filing History |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Fate Therapeutics, Inc. FATE |
The Vanguard Group | 7,675,787 8.040% |
897,200 (+13.24%) |
Filing History |
| 2022-02-09 2:37 pm Sale |
2021-12-31 | 13G | Fate Therapeutics, Inc. FATE |
ARK Investment Management LLC | 10,312,167 10.800% |
-478,256 (-4.43%) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
7,060,552 7.400% |
389,011 (+5.83%) |
Filing History |
| 2021-10-12 09:25 am Sale |
2021-10-08 | 13G | Fate Therapeutics, Inc. FATE |
FMR CORP | 2,249,450 2.363% |
-5,355,454 (-70.42%) |
Filing History |
| 2021-09-10 2:48 pm Purchase |
2021-08-31 | 13G | Fate Therapeutics, Inc. FATE |
ARK Investment Management LLC | 10,790,423 11.340% |
10,790,423 (New Position) |
Filing History |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Fate Therapeutics, Inc. FATE |
The Vanguard Group | 6,778,587 7.770% |
6,778,587 (New Position) |
Filing History |
| 2021-02-08 10:21 am Purchase |
2021-02-05 | 13G | Fate Therapeutics, Inc. FATE |
FMR CORP | 7,604,904 8.716% |
719,321 (+10.45%) |
Filing History |
| 2021-02-03 12:34 pm Unchanged |
2020-12-31 | 13G | Fate Therapeutics, Inc. FATE |
Victory Capital Management, Inc. | 2,091,280 2.400% |
0 (Unchanged) |
Filing History |
| 2021-02-03 10:51 am Sale |
2020-12-31 | 13G | Fate Therapeutics, Inc. FATE |
Victory Capital Management, Inc. | 2,091,280 2.400% |
-2,137,874 (-50.55%) |
Filing History |
| 2021-01-29 09:57 am Purchase |
2020-12-31 | 13G | Fate Therapeutics, Inc. FATE |
BLACKROCK INC BLK |
6,671,541 7.600% |
878,854 (+15.17%) |
Filing History |
| 2021-01-12 4:18 pm Purchase |
2021-01-08 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 12,993,888 14.100% |
332,152 (+2.62%) |
Filing History |
| 2020-06-17 8:26 pm Purchase |
2020-06-11 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 12,661,736 14.900% |
1,434,928 (+12.78%) |
Filing History |